Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4828715 | 0.98 | CES1 (0.42) | CES1TDP1MAPK1KMT2AMEN1 | |
| SCHEMBL7096723 | 0.81 | TDP1 (0.43) | CES1TDP1MAPK1KMT2AMEN1 | |
| SCHEMBL28201569 | 0.80 | LMNA (0.52) | CES1TDP1MAPK1KMT2AMEN1 | |
| SCHEMBL27701934 | 0.78 | LMNA (0.50) | CES1TDP1MAPK1KMT2AMEN1 | |
| SCHEMBL29234727 | 0.78 | CA2 (0.50) | CES1TDP1MAPK1KMT2AMEN1 | |
| SCHEMBL489956 | 0.76 | MAPT (0.44) | CES1TDP1MAPK1KMT2AMEN1 | |
| SCHEMBL27966805 | 0.75 | CES2 (0.53) | CES1KMT2AMEN1KDM4EMAPT | |
| SCHEMBL11394434 | 0.74 | ELANE (0.47) | CES1TDP1MAPK1KMT2AMEN1 | |
| SCHEMBL28399559 | 0.74 | CES1 (0.43) | CES1TDP1MAPK1KMT2AMEN1 | |
| SCHEMBL1816682 | 0.74 | MAPT (0.50) | CES1TDP1MAPK1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3260863-B1 | METHOD FOR PERFORMING MULTIPLEX ANALYSIS OF TWO OR MORE ANALYTES | FLUIDIGM CANADA INC (CA) | 2021-03-10 | — | — | EP | disclosed |
| US-20200362062-A1 | POLYMER BACKBONE ELEMENT TAGS | STANDARD BIOTOOLS CANADA INC. (CA) | 2020-11-19 | — | — | US | disclosed |
| US-10752707-B2 | Polymer backbone element tags | FLUIDIGM CANADA INC. (CA) | 2020-08-25 | — | — | US | disclosed |
| US-10669358-B2 | Polymer backbone element tags | FLUIDIGM CANADA INC. (CA) | 2020-06-02 | — | — | US | disclosed |
| US-20190345272-A1 | POLYMER BACKBONE ELEMENT TAGS | STANDARD BIOTOOLS CANADA INC. (CA) | 2019-11-14 | — | — | US | disclosed |
| US-20190077890-A1 | POLYMER BACKBONE ELEMENT TAGS | FLUIDIGM CANADA INC. (CA) | 2019-03-14 | — | — | US | disclosed |
| US-10072104-B2 | Polymer backbone element tags | FLUIDIGM CANADA INC. (CA) | 2018-09-11 | — | — | US | disclosed |
| EP-3260863-A1 | METHOD FOR PERFORMING MULTIPLEX ANALYSIS OF TWO OR MORE ANALYTES | Fluidigm Canada Inc. (CA) | 2017-12-27 | — | — | EP | disclosed |
| EP-2960263-B1 | POLYMER BACKBONE ELEMENT TAGS | FLUIDIGM CANADA INC (CA) | 2017-07-12 | — | — | EP | disclosed |
| EP-2021793-B1 | POLYMER BACKBONE ELEMENT TAGS | FLUIDIGM CANADA INC (CA) | 2017-04-26 | — | — | EP | disclosed |
| US-20040082079-A1 | Low affinity screening method | GRAFFINITY PHARMACEUTICALS AG. (DE) | 2004-04-29 | — | — | US | disclosed |
| EP-1360489-A1 | LOW AFFINITY SCREENING METHOD | Graffinity Pharmaceuticals Aktiengesellschaft (DE) | 2003-11-12 | — | — | EP | disclosed |
| US-6610837-B1 | Preparation of an oligonucleotide compound of given formula by reacting with given compounds, followed by oxidation or sulfurization | ISIS PHARMACEUTICALS, INC. | 2003-08-26 | — | — | US | disclosed |
| US-20020127577-A1 | Bioactive sensors | GRAFFINITY PHARMACEUTICALS AG (DE) | 2002-09-12 | — | — | US | disclosed |
| WO-2002063299-A1 | LOW AFFINITY SCREENING METHOD | GRAFFINITY PHARMACEUTICALS AG (DE) | 2002-08-15 | — | — | WO | disclosed |
| WO-2000055179-A1 | NOVEL PHOSPHATE AND THIOPHOSPHATE PROTECTING GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | disclosed |
| US-6121437-A | SYNTHESIS OF OLIGONUCLEOTIDES USING OLIGONUCLEOTIDES OR NUCLEOTIDES WITH PROTECTED INTERNUCLEOSIDIC PHOSPHORUS FUNCTIONALITIES WHICH CAN BE REMOVED UNDER MILD CONDITIONS AND PRODUCE NONTOXIC BY-PRODUCTS | ISIS PHARMACEUTICALS, INC. (US) | 2000-09-19 | — | — | US | disclosed |
| CN-1094409-A | 3 '-thioes derivatives of oxygen-propargyl-trifluorothymidine, it method for making and as the purposes of carcinostatic agent | MITSUI TOATSU CHEMICALS (JP) | 1994-11-02 | — | — | CN | disclosed |
| EP-0601520-A1 | Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1994-06-15 | — | — | EP | disclosed |
| US-4518682-A | CONTAINING COMPOUND WHICH GIVES FOGGING EFFECT | FUJI PHOTO FILM CO., LTD. (JP) | 1985-05-21 | — | — | US | disclosed |